What Diker Management LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1276525 · Filed Nov 16, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 6.5K |
| ±0% |
| $6.3M |
| 5.5% |
NBISNebius Group N.V. | 26K | ±0% | $6.1M | 5.4% |
SMTCSemtech Corp | 28.9K | ±0% | $5.1M | 4.5% |
AMKRAmkor Technology, Inc. | 90K | +50.0% | $4.7M | 4.1% |
AAPLApple Inc. | 13.1K | ±0% | $4.4M | 3.8% |
AMDAdvanced Micro Devices Inc | 6.5K | −50.0% | $4M | 3.5% |
SNDKSandisk Corp | 2K | New | $3.4M | 3% |
CRWVCoreWeave, Inc. | 35.1K | +251.1% | $3.1M | 2.7% |
UCTTUltra Clean Holdings, Inc. | 27K | ±0% | $2.2M | 1.9% |
ICHRIchor Holdings, Ltd. | 32.5K | ±0% | $2M | 1.8% |
ZBRAZebra Technologies Corp | 5K | ±0% | $1.9M | 1.6% |
IRENIren Ltd | 43.4K | New | $1.8M | 1.6% |
MSFTMicrosoft Corp | 3.2K | ±0% | $1.7M | 1.4% |
GLWCorning Inc | 10K | New | $1.5M | 1.3% |
FFIVF5, Inc. | 2.9K | ±0% | $1.3M | 1.1% |
BVSBioventus Inc. | 75.1K | ±0% | $1M | 0.9% |
ANIKAnika Therapeutics, Inc. | 51.7K | −3.7% | $1M | 0.9% |
PLSEPulse Biosciences, Inc. | 19K | ±0% | $948.5K | 0.8% |
HUTHut 8 Corp. | 10.5K | New | $904.1K | 0.8% |
TOLToll Brothers, Inc. | 6.4K | ±0% | $862.4K | 0.8% |
INODInnodata Inc | 13K | New | $854.9K | 0.7% |
GMGeneral Motors Co | 9K | ±0% | $693K | 0.6% |
LNTHLantheus Holdings, Inc. | 5.7K | ±0% | $569.5K | 0.5% |
MMM3M Co | 2.9K | ±0% | $482.8K | 0.4% |
CVXChevron Corp | 2.2K | ±0% | $444.4K | 0.4% |
GLDSPDR Gold Trust | 1.1K | ±0% | $433K | 0.4% |
AEOAmerican Eagle Outfitters Inc | 20K | ±0% | $356.1K | 0.3% |
TDUPThredUp Inc. | 160.6K | ±0% | $340.4K | 0.3% |
AORTArtivion, Inc. | 13.5K | ±0% | $308.1K | 0.3% |
JNJJohnson & Johnson | 1.2K | ±0% | $306K | 0.3% |
DHIHorton D R Inc | 2.2K | −10.4% | $305.8K | 0.3% |
SPRYARS Pharmaceuticals, Inc. | 65.5K | ±0% | $282.3K | 0.2% |
TMOThermo Fisher Scientific Inc. | 400 | ±0% | $270K | 0.2% |
BIRKBirkenstock Holding plc | 6.7K | ±0% | $217.1K | 0.2% |
LENLennar Corp | 2.5K | New | $206.9K | 0.2% |
VNDAVanda Pharmaceuticals Inc. | 21.9K | ±0% | $107.4K | 0.1% |
LXRXLexicon Pharmaceuticals, Inc. | 20K | ±0% | $37.5K | 0.1% |
JSPRJasper Therapeutics, Inc. | 35K | ±0% | $20.3K | 0.1% |